Histologically confirmed primary invasive breast cancer;
Planned to receive ≥ 8 weeks of weekly neoadjuvant chemotherapy (utidelone plus cisplatin);
ECOG performance status: 0-1;
You may not be if
Distant metastasis;
Presence of sensory or motor neurological disorders, or symptoms related to peripheral neuropathy with CTCAE grade ≥ 2, or currently receiving medication for peripheral neuropathy;
Conditions affecting limb function;
Known allergy to glove materials (e.g., latex)
Clareo Health | Simple Surgical Glove Compression to Prevent Chemotherapy-Induced Peripheral Neuropathy
